- Home
- ICUI vs DAVE Comparison
ICUI vs DAVE Comparison
Compare ICUI & DAVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ICUI
- DAVE
- Stock Information
- Founded
- ICUI 1984
- DAVE 2017
- Country
- ICUI United States
- DAVE United States
- Employees
- ICUI N/A
- DAVE N/A
- Industry
- ICUI Medical/Dental Instruments
- DAVE Retail: Computer Software & Peripheral Equipment
- Sector
- ICUI Health Care
- DAVE Technology
- Exchange
- ICUI Nasdaq
- DAVE Nasdaq
- Market Cap
- ICUI 3.4B
- DAVE 2.9B
- IPO Year
- ICUI 1992
- DAVE N/A
- Fundamental
- Price
- ICUI $127.40
- DAVE $232.73
- Analyst Decision
- ICUI Strong Buy
- DAVE Strong Buy
- Analyst Count
- ICUI 5
- DAVE 6
- Target Price
- ICUI $196.75
- DAVE $243.83
- AVG Volume (30 Days)
- ICUI 186.2K
- DAVE 607.1K
- Earning Date
- ICUI 08-07-2025
- DAVE 08-06-2025
- Dividend Yield
- ICUI N/A
- DAVE N/A
- EPS Growth
- ICUI N/A
- DAVE N/A
- EPS
- ICUI N/A
- DAVE 3.70
- Revenue
- ICUI $2,420,093,000.00
- DAVE $381,425,000.00
- Revenue This Year
- ICUI N/A
- DAVE $37.77
- Revenue Next Year
- ICUI N/A
- DAVE $18.45
- P/E Ratio
- ICUI N/A
- DAVE $62.90
- Revenue Growth
- ICUI 7.22
- DAVE 39.31
- 52 Week Low
- ICUI $117.92
- DAVE $28.74
- 52 Week High
- ICUI $196.26
- DAVE $286.45
- Technical
- Relative Strength Index (RSI)
- ICUI 46.81
- DAVE 54.94
- Support Level
- ICUI $124.39
- DAVE $189.00
- Resistance Level
- ICUI $134.04
- DAVE $246.16
- Average True Range (ATR)
- ICUI 3.75
- DAVE 16.73
- MACD
- ICUI 0.18
- DAVE 2.16
- Stochastic Oscillator
- ICUI 47.55
- DAVE 78.82
About ICUI ICU Medical Inc.
ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (43% of consolidated revenue), infusion systems (28%), and vital care (29%). The combined entity remains primarily US-focused, generating over 63% of its sales domestically.
About DAVE Dave Inc.
Dave Inc is a financial services company. It is engaged in offering banking app that offers its customers banking, financial insights, overdraft protection, building credit and finding side gigs.